Related Experiment Videos

Hb Olivet (HBA1: C.40G > A; p.Ala14Thr), a Novel Silent Hemoglobin Variant in Two Families of Distinct Origin

Cornelis L Harteveld1, Serge Pissard2, Anna M H Korver3

  • 1a Hemoglobinopathies Laboratory, Department of Human and Clinical Genetics , Leiden University Medical Center (LUMC) , Leiden , the Netherlands.

Hemoglobin
|September 15, 2016
PubMed

Insights

A novel hemoglobin (Hb) variant, Hb Olivet, behaves as a silent Hb. Its clinical presentation, potentially influenced by iron levels, ranges from asymptomatic to mild microcytic anemia in carriers.

Area of Science:

  • Hematology
  • Genetics
  • Molecular Biology

Background:

  • Hemoglobin (Hb) variants can impact red blood cell characteristics and oxygen transport.
  • Silent Hb variants present diagnostic challenges due to minimal or absent phenotypic expression.

Purpose of the Study:

  • To characterize a novel hemoglobin variant, Hb Olivet [α13(A11)Ala→Thr], identified in two families.
  • To describe the genotype-phenotype correlation and clinical behavior of Hb Olivet carriers.

Main Methods:

  • Hemoglobin analysis using capillary electrophoresis (CE) and high-performance liquid chromatography (HPLC).
  • Clinical evaluation of affected individuals, including red blood cell indices and iron status.
  • Genetic analysis to confirm the novel Hb variant.

Main Results:

  • Hb Olivet was identified as a novel silent Hb variant.
  • Clinical manifestations in carriers varied, with some showing borderline or normal red blood cell indices and others presenting with mild microcytic hypochromic anemia.
  • Iron depletion appeared to be a significant factor influencing the phenotype in carriers.

Conclusions:

  • Hb Olivet is a silent hemoglobinopathy with variable expressivity.
  • Iron status plays a crucial role in the phenotypic presentation of Hb Olivet carriers.
  • Further investigation into genotype-phenotype correlations in hemoglobinopathies is warranted.

Related Concept Videos